Actively Recruiting
Study of Umbilical Cord Mesenchymal Stem Cells Added to Standard Treatment for Acute ST-Elevation Myocardial Infarction Patients
Led by Ever Supreme Bio Technology Co., Ltd. · Updated on 2026-09-23
41
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the use of allogeneic umbilical cord mesenchymal stem cells UMSC01 as an additional treatment for patients who have experienced an acute ST-elevation myocardial infarction STEMI, a type of heart attack. This Phase IIa study follows a previous Phase I trial that evaluated the safety and potential effects of UMSC01 given through intracoronary infusion followed by intravenous infusion. The study aims to assess the efficacy and safety of UMSC01 alongside the standard treatment for STEMI, which includes immediate reperfusion procedures. Participants will receive UMSC01 through a two-step process first, an intracoronary infusion of the stem cells on the 4th or 5th day after the heart attack, followed by an intravenous infusion two days later. The study compares this treatment with standard care alone in a randomized, open-label, parallel-group design. The standard care involves procedures such as primary percutaneous coronary intervention, aspiration thrombectomy, and antithrombotic therapy, all performed within 12 hours of symptom onset. Throughout the study, participants will undergo various assessments including monitoring for adverse events, cardiopulmonary exercise testing, echocardiography, and other heart function tests over follow-up periods ranging from 1 month to 24 months. Researchers will evaluate safety by tracking adverse reactions and serious events, while efficacy will be measured by heart function and exercise capacity. Participants will have regular visits for testing and monitoring during these follow-up periods to understand the impact and safety of the UMSC01 treatment as an addition to standard care.
CONDITIONS
Brief Title
Evaluate the Efficacy and Safety of Allogeneic Umbilical Cord Mesenchymal Stem Cells as an Add-On Treatment for Acute ST-elevation Myocardial Infarction (STEMI) Patients
Research Team
S
Sammi Hsu
J
Jack Tsai
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here